CGA
QDEL icon

Crescent Grove Advisors’s QuidelOrtho QDEL Stock Holding History

Crescent Grove Advisors’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,000
Closed -$225K – 288
2022
Q1 		$225K Hold
2,000
– – 0.02% 268
2021
Q4 		$270K Buy
+2,000
New +$278K 0.03% 247
2021
Q3 		– Sell
-2,184
Closed -$280K – 285
2021
Q2 		$280K Buy
+2,184
New +$257K 0.03% 206

Other funds holding QDEL

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Crescent Grove Advisors's QDEL Position: Q2 2022 in Review

Crescent Grove Advisors sold out of QuidelOrtho (QDEL) in Q2 2022, closing a stake of 2,000 shares — an estimated $225K sold.

Crescent Grove Advisors first reported a position in QDEL in Q2 2021 and held it in 3 quarters. The position peaked at $280K in Q2 2021. 347 funds tracked by Wall St. Rank hold QDEL as of Q2 2022.

  • Crescent Grove Advisors reported no remaining QuidelOrtho position as of Q2 2022 after selling out during the quarter.
  • Crescent Grove Advisors sold 2,000 QuidelOrtho shares in Q2 2022, an estimated $225K.
  • Crescent Grove Advisors first reported a position in QuidelOrtho in Q2 2021 and held it in 3 quarters.
  • Crescent Grove Advisors's QuidelOrtho position peaked at $280K in Q2 2021.
  • 347 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2022.

Based on Crescent Grove Advisors's 13F filing for Q2 2022, filed 20 Jul 2022.